Found: 23
Select item for more details and to access through your institution.
Olfactory threshold predicts treatment response in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1541, doi. 10.1177/13524585221079744
- By:
- Publication type:
- Article
Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 684, doi. 10.1177/1352458520935724
- By:
- Publication type:
- Article
Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1682, doi. 10.1177/1352458519882279
- By:
- Publication type:
- Article
Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 6, p. 706, doi. 10.1177/1352458519838205
- By:
- Publication type:
- Article
Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 69, doi. 10.1177/1352458518816614
- By:
- Publication type:
- Article
Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 57, doi. 10.1177/1352458518814113
- By:
- Publication type:
- Article
Change of olfactory function as a marker of inflammatory activity and disability progression in MS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 267, doi. 10.1177/1352458517745724
- By:
- Publication type:
- Article
Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 196, doi. 10.1177/1352458517740216
- By:
- Publication type:
- Article
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, p. 1, doi. 10.1177/2055217320966344
- By:
- Publication type:
- Article
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, n. 4, p. 1, doi. 10.1177/2055217320966344
- By:
- Publication type:
- Article
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319885987
- By:
- Publication type:
- Article
Serum hepcidin levels in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319885984
- By:
- Publication type:
- Article
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 2, p. 1, doi. 10.1177/2055217319848463
- By:
- Publication type:
- Article
Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02435
- By:
- Publication type:
- Article
Evaluation of a self-administered iPad<sup>®</sup>-based processing speed assessment for people with multiple sclerosis in a clinical routine setting.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 6, p. 3268, doi. 10.1007/s00415-024-12274-8
- By:
- Publication type:
- Article
Influence of physical activity on serum vitamin D levels in people with multiple sclerosis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234333
- By:
- Publication type:
- Article
Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182462
- By:
- Publication type:
- Article
Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis—The PaSiMS II study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0181458
- By:
- Publication type:
- Article
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1200146
- By:
- Publication type:
- Article
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02665-6
- By:
- Publication type:
- Article
Smoking is not associated with higher prevalence of JC virus in MS patients.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 5, p. 907, doi. 10.1007/s10096-018-3204-z
- By:
- Publication type:
- Article
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 6, p. 2037, doi. 10.1111/ene.14829
- By:
- Publication type:
- Article
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1609, doi. 10.1111/ene.14705
- By:
- Publication type:
- Article